23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.